A narrative review of COVID-19: magnesium isoglycyrrhizinate as a potential adjuvant treatment.

Tang, Chuanfeng; Ding, Hong; Sun, Yang; Han, Zhujun; Kong, Lingdong

Tang, Chuanfeng; Ding, Hong; Sun, Yang; Han, Zhujun; Kong, Lingdong.

Afiliação

Tang C; State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China.
Ding H; State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China.
Sun Y; State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China.
Han Z; Department of Pharmacy, Affiliated to Dongtai Hospital of Nantong University, Dongtai, China.
Kong L; State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China.

Ann Palliat Med ; 10(4): 4777-4798, 2021 Apr.

Article em En | MEDLINE | ID: mdl-33894736

Assuntos

COVID-19; Saponinas; China; Humanos; SARS-CoV-2; Saponinas/uso terapêutico; Triterpenos

Palavras-chave

COVID-19; Magnesium isoglycyrrhizinate (MgIG); anti-virus; cytokine storm; multiple organ damage

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Medicinas Tradicionais: Medicinas_tradicionales_de_asia / Medicina_china Assunto principal: Saponinas / COVID-19 País/Região como assunto: Asia Idioma: En Revista: Ann Palliat Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google